Other investigators including Kuipers et al. [23], Buckley et al. [24], Coombes et al. [25], and Duff et al. [26] analyzed IGF-1 actions after 4–8 weeks of BC supplementation and observed no significant improvement. This evidence concerns the gene IGF1 and breast cancer.